Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Vadrevu KM, Reddy S, Jogdand H, Ganneru B, et al. Immunogenicity and reactogenicity of an inactivated SARS-CoV-2 vaccine (BBV152) in children aged 2-18 years: interim data from an open-label, non-randomised, age de-escalation phase 2/3 study. Lancet Infect Dis 2022 Jun 16. pii: S1473-3099(22)00307.
PMID: 35717995


Privacy Policy